FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   DERMASTAR INTERNATIONAL, LLC 2. Date of Event Requiring Statement (Month/Day/Year) 12/12/2011 3. Issuer Name and Ticker or Trading Symbol Imprimis Pharmaceuticals, Inc. [IMMY] (Last) (First) (Middle) 1302 WAUGH DRIVE, STE 618 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) HOUSTON, TX 77019 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock (1) 8,240,045 D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A Convertible Preferred Stock (2)	02/28/2012	02/28/2012	Common Stock	7,498,500	$ 0.0017	D	Â
Warrants (3)	04/30/2012	04/29/2015	Common Stock	241,308	$ 1.185	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
DERMASTAR INTERNATIONAL, LLC 1302 WAUGH DRIVE STE 618 HOUSTON, TX 77019	Â	  X	Â	Â

Signatures

Mark L. Baum		04/27/2012
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	DermaStar International, LLC ("DermaStar") is the direct beneficial owner of 8,240,045 shares of the Issuer's common stock. Mr. Mark L. Baum and Mr. Robert Kammer are the managing members of DermaStar, and each holds an ownership interest in DermaStar, and as managing members of DermaStar, may be deemed to have voting and dispositive power over the 8,240,045 shares of common stock owned by DermaStar. Both Mr. Baum and Mr. Kammer disclaim beneficial ownership over such shares.
(2)	DermaStar is the direct beneficial owner of 10 shares of the Issuer's Series A Convertible Preferred Stock (the "Series A Preferred"). The Series A Preferred are convertible into a total of 7,498,500 shares of Common Stock. Mr. Baum and Mr. Kammer are the managing members of DermaStar, and each holds an ownership interest in DermaStar, and as managing members of DermaStar, may be deemed to have voting and dispositive power of the 7,498,500 shares of Common Stock underlying the Series A Preferred owned by DermaStar. Both Mr. Baum and Mr. Kammer disclaim beneficial ownership over such shares.
(3)	DermaStar is the direct beneficial owner of warrants to purchase up to 241,308 shares of the Issuer's Common Stock at an exercise price of $1.185 (the "Warrants"). The Warrants expire on the third anniversary of the issuance date. Mr. Baum and Mr. Kammer are the managing members of DermaStar, and each holds an ownership interest in DermaStar, and as managing members of DermaStar, may be deemed to have voting and dispositive power of the Warrants and 241,308 shares of Common Stock underlying the Warrants owned by DermaStar. Both Mr. Baum and Mr. Kammer disclaim beneficial ownership over such shares.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.